| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $627.6M | +32.6% |
| R&D Expense | $115.0M | +42.4% |
| SG&A Expense | $90.0M | +39.8% |
| Operating Income | -$22.2M | +26.5% |
| Pre-tax Income | $1.6M | +106.4% |
| Income Tax | $13.6M | +56.0% |
| Net Income | -$12.0M | +64.8% |
| EPS (Basic) | -$0.03 | +90.9% |
| EPS (Diluted) | -$0.03 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $543.3M | +16.6% |
| Accounts Receivable | $12.9M | -7.0% |
| Current Assets | $6.47B | +30.4% |
| Total Assets | $6.59B | +29.8% |
| Current Liabilities | $5.98B | +32.9% |
| Long-term Debt | $16.1M | +18.1% |
| Total Liabilities | $6.05B | +31.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $84.0M | +319.5% |
| Capital Expenditures | $10.5M | +52.4% |
| Investing Cash Flow | $5.7M | -43.5% |
| Financing Cash Flow | $1.46B | +4.7% |
| Free Cash Flow | $73.5M | +459.7% |
| +90.9% |
| Stockholders' Equity |
| $545.3M |
| +11.9% |